» Articles » PMID: 26046666

Values of the Minimal Clinically Important Difference for the Neuropsychiatric Inventory Questionnaire in Individuals with Dementia

Overview
Specialty Geriatrics
Date 2015 Jun 6
PMID 26046666
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To estimate the minimal clinically important difference (MCID) for the Neuropsychiatric Inventory Questionnaire (NPI-Q), a widely used measure of behavioral and psychological symptoms of dementia (BPSDs) and associated caregiver stress.

Design: Ten registered nurses rated the severity of BPSDs and caregiver distress using the NPI-Q during six monthly assessments and an external reference, a 7-point Likert-type global rating of BPSDs change during five monthly assessments from the second to the sixth month. An anchor-based (global ratings of change) approach and a distribution-based (standard error of measurement) approach were used to determine the MCID for the NPI-Q severity and distress subscales.

Setting: Long-term care facility.

Participants: Nonbedridden residents with dementia (n = 45) and registered nurses (n = 10).

Measurements: NPI-Q (severity and caregiver distress subscales) and global ratings of changes in BPSDs on a 7-point Likert-type scale.

Results: The NPI-Q MCID ranges were 2.77 to 3.18 for severity and 3.10 to 3.95 for distress. Residents in the highest NPI-Q tertile at baseline had higher MCID severity (3.62) and distress (5.08) scores than those in the lowest tertile (severity (2.40), distress (3.10)).

Conclusion: This study provides an estimate of the MCID for severity and distress subscales of the NPI-Q, which can help clinicians and researchers determine whether NPI-Q change scores within a group of individuals with dementia are beyond measurement error and are clinically important.

Citing Articles

Health System, Community-Based, or Usual Dementia Care for Persons With Dementia and Caregivers: The D-CARE Randomized Clinical Trial.

Reuben D, Gill T, Stevens A, Williamson J, Volpi E, Lichtenstein M JAMA. 2025; .

PMID: 39878968 PMC: 11780506. DOI: 10.1001/jama.2024.25056.


Effects of Yoga-Like Exercises on Mild and Moderate Alzheimer Disease: A Randomized Controlled Trial Protocol.

Moncer R, Hajji H, Naija S, Ben Amor S, Jemni S, Ben Saad H Tunis Med. 2025; 103(1):58-64.

PMID: 39812195 PMC: 11906243. DOI: 10.62438/tunismed.v103i1.5341.


Combined Effect of tDCS and Motor or Cognitive Activity in Patients with Alzheimer's Disease: A Proof-of-Concept Pilot Study.

Fonte C, Rotundo G, Varalta V, Filosa A, Muti E, Barletta C Brain Sci. 2024; 14(11).

PMID: 39595863 PMC: 11591620. DOI: 10.3390/brainsci14111099.


Practical Assessment of Neuropsychiatric Symptoms: Updated Reliability, Validity, and Cutoffs for the Neuropsychiatric Inventory Questionnaire.

Gonzalez D, Finley J, Patel S, Soble J Am J Geriatr Psychiatry. 2024; 33(5):524-534.

PMID: 39551647 PMC: 11903187. DOI: 10.1016/j.jagp.2024.10.014.


Preliminary translation of 'Reducing Disability in Alzheimer's Disease' among individuals with intellectual disabilities and caregiver dyads.

Ptomey L, Barton K, Swinford E, Bodde A, George A, Gorczyca A J Appl Res Intellect Disabil. 2024; 37(3):e13239.

PMID: 38621995 PMC: 11067498. DOI: 10.1111/jar.13239.